WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997021680) QUINOLINE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/021680    International Application No.:    PCT/EP1996/005203
Publication Date: 19.06.1997 International Filing Date: 22.11.1996
Chapter 2 Demand Filed:    07.06.1997    
IPC:
C07D 215/52 (2006.01)
Applicants: SMITHKLINE BEECHAM S.P.A. [IT/IT]; Via Zambeletti, I-20021 Baranzate di Bollate (IT) (For All Designated States Except US).
GIARDINA, Giuseppe, Arnaldo, Maria [IT/IT]; (IT) (For US Only).
GRUGNI, Mario [IT/IT]; (IT) (For US Only).
RAVEGLIA, Luca, Francesco [IT/IT]; (IT) (For US Only).
FARINO, Carlo [IT/IT]; (IT) (For US Only)
Inventors: GIARDINA, Giuseppe, Arnaldo, Maria; (IT).
GRUGNI, Mario; (IT).
RAVEGLIA, Luca, Francesco; (IT).
FARINO, Carlo; (IT)
Agent: RUTTER, Keith; SmithKline Beecham, Corporate Intellectual Property, Two New Horizons Court, Brentford, Middlesex TW8 9EP (GB)
Priority Data:
MI95A002461 24.11.1995 IT
MI96A001689 02.08.1996 IT
Title (EN) QUINOLINE DERIVATIVES
(FR) DERIVES DE QUINOLINE
Abstract: front page image
(EN)A compound, or a solvate or a salt thereof, of formula (I), wherein, Ar is an optionally substituted aryl or a C¿5-7? cycloalkdienyl group, or an optionally substituted single or fused ring aromatic heterocyclic group; R, R¿1?, R¿2? and R¿3? are as defined in the description; a process for the preparation of such a compound, a pharmaceutical composition containing such a compound or composition in medicine.
(FR)On décrit un composé, ou un solvate ou sel de celui-ci, répondant à la formule (I) dans laquelle Ar représente aryle éventuellement substitué ou un groupe cycloalkdiényle C¿5-7?, ou un groupe hétérocyclique aromatique à noyau simple ou condensé, éventuellement substitué; R, R¿1?, R¿2? et R¿3? sont tels que définis dans la description. On décrit également un procédé de préparation d'un tel composé, une composition pharmaceutique contenant celui-ci, ainsi que l'utilisation de ce composé ou de cette composition en médecine.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)